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The lymphatic network is complex and difficult to visualize in real-time in vivo. Moreover, the direction of flow
within lymphatic networks is often unpredictable especially in areas with well-developed ‘‘watershed’’ or
overlapping lymphatics. Herein, we report a method of in vivo real-time multicolor lymphatic imaging using
cadmium–selenium quantum dots (Qdots) with a fluorescence imaging system that enables the simultaneous
visualization of up to five distinct lymphatic basins in real-time. Five visually well-distinguishable carboxyl-
Qdots (Qdot 545, 565, 585, 605, and 655) were selected and injected subdermally into mice at five different sites,
and serially imaged in vivo or in situ under surgery with real-time multicolor lymphatic imaging. In all seven
mice, in vivo lymphatic images successfully distinguished all five lymphatic basins with different colors in real-
time. These visualizations of lymph node lasted up to at least 7 days. This method could have a considerable
potential in lymphatic research for studying the anatomy and flow within the lymphatic system as well as in
some limited clinical settings where real-time visible fluorescence could facilitate procedures under surgery or
endoscopy.
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INTRODUCTION
The lymphatic network is complex and difficult to visualize
in vivo. The lymphatics are composed of terminal afferent
‘‘collector’’ ducts that enter the lymphatic sinus in the outer
cortex of lymph nodes where innate immunity, a primary
defense, can take place. Efferent lymphatic channels emerge
from the hilum of the lymph node and generally interconnect
with other lymph nodes before finally joining the deep
lymphatics, which in turn enter the systemic vascular system
through the thoracic duct. Each lymph node can receive
lymphatic fluid from multiple afferent lymphatic channels
(Hama et al., 2007a, b). Moreover, the direction of flow
within lymphatic networks is often unpredictable especially
in areas with a well-developed ‘‘watershed’’ or overlapping
lymphatics. However, lymphatic flow can be altered during
disease states and a method to image the lymphatics is
potentially a useful research tool. Several lymphatic imaging
methods are now available both pre-clinically and clinically
(Barrett et al., 2006; Sharma et al., 2008). These include
magnetic resonance, radionuclide and optical methods
(Barrett et al., 2006). Optical imaging is unique in that each
fluorophore emits a unique spectral wavelength thus permit-
ting simultaneous depiction of multiple lymphatics at the
same time, provided that there is minimal overlap of the
emission spectra of the fluorophores. Moreover, optical
imaging can potentially be performed in real-time during
surgical procedures. The simultaneous multicolor imaging of
five different lymphatic basins using quantum dots (Qdots) or
dendrimer-conjugated organic fluorophores has been re-
ported (Kobayashi et al., 2007a, b). However, such imaging
requires lengthy spectral unmixing that prevents real-time
display. Moreover, the full potential of Qdots were not
realized in previous studies; the emission profiles of Qdots
are sharp and can be tuned to emit a variety of wavelengths,
from a single, lower wavelength excitation light (Goldman
et al., 2004). Because the emission profiles are so sharp, it is
possible to visualize five different Qdots in the visible range
(Figure 1a and b) even with the naked eye. Herein, we report
the development of an in vivo visible, real-time multicolor
lymphatic imaging system using five different Qdots to
visualize five distinct lymphatic basins in the neck and
axillary region in mice.
RESULTS
In vivo real-time multicolor lymphatic imaging
Among eight commercially available carboxyl-coated Qdots,
five cadmium–selenium Qdots (Qdot 545, 565, 585, 605, and
655) were selected in this experiment because of adequate
visual color differences (Figure 1a and b). These five Qdots
were injected subdermally into five sites as shown in Figure
1c. In all seven mice, in vivo images successfully resolved all
five lymphatic basins with different colors using real-time and
spectral fluorescence imaging (Figure 2a and b). Compared
with spectral imaging, real-time multicolor fluorescence
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Abbreviation: Qdot, quantum dot
imaging did not require image post-processing and thus could
be displayed and recorded in real-time (Supplementary
Movies S1, S2). The value of multicolor fluorescence imaging
is demonstrated in the right superficial neck lymph node of
one animal that received drainage from two different afferent
lymphatics (arrows in Figure 2b). The upper half of this lymph
node exhibited green fluorescence (Qdot 545 from the
injection at the chin), whereas the lower half of the node
exhibited pale-orange fluorescence (Qdot 585 from the
injection in the right ear). These findings became more
obvious after tugging on the lymph node in real-time with
forceps during in vivo imaging (Supplementary Figure S1).
Serial in vivo fluorescence imaging
The three mice that were not killed underwent serial in vivo
fluorescence imaging to investigate the duration of nodal
visualization. Imaging sessions took place at 1, 2, and 7 days
after injection of Qdots. Compared to the immediate post
injection images, day 1 images were considerably weaker
(Figure 3) probably because of rapid washing out of the
Qdots. However, there was little subsequent loss in the signal
enabling imaging at day 7 (Figure 3). Despite this signal loss,
all fluorescent emissions from the lymph nodes were clearly
seen after stretching the overlying skin when imaging with a
video camera as shown in Supplementary Figure S2.
Histological analysis
After removal and ex vivo fluorescence imaging, the lymph
nodes were evaluated by fluorescence microscopy and
immunohistochemistry. On day 0 the Qdots were mainly in
the lymphatic sinuses, whereas the lymphoid follicles and
lymphatic cords were devoid of Qdots (Figure 4a). The Qdots
distributed within the node in an expected distribution:
lymph fluid from afferent lymphatic vessels typically enters
the subcapsular sinus and then flows through the lateral
transverse and medullary sinuses (Willard-Mack, 2006).
At high magnification, microscopy showed that the Qdots
mostly accumulated within the cytoplasm of histiocytic
cells including macrophages and dendritic cells in the
lymphatic sinuses adjacent to intranodal channels
(Figure 4b and d, Supplementary Figures S3 and S4). The
distribution of the Qdots after 7 days was sparser than that of
day 0, but still showed the same pattern (Figure 4c). The
majority of the Qdots were taken up by macrophages and
dendritic cells whereas a minor fraction was probably
washed out within a day.
DISCUSSION
A unique feature of Qdots is that they are so bright that they
can be seen with the naked eye. Currently, most of
fluorescence lymphatic imaging is performed with near-
infrared fluorophores due to its superior penetration of tissue
and lower contamination with autofluorescence (Barrett
et al., 2006; Frangioni et al., 2007; Sharma et al., 2008).
However, because near-infrared fluorescence is invisible to
the human eye, it must be imaged with a specially designed
near-infrared fluorescence camera (Tanaka et al., 2006), and
multicolor imaging is only possible with spectral imaging that
allows unmixing of the fluorescence from the background
signal (Kobayashi et al., 2007a, b). This process requires a
lengthy acquisition time (42minutes) and further post
processing (requiring another several minutes), and thus,
cannot occur in real-time. Our method employs visible-light
Qdots, which are so bright that in spite of their lower
wavelength, nonetheless penetrate the skin sufficiently for
in vivo lymphatic imaging. This has advantages for guiding
procedures, both pre-clinically and clinically, which often
demand real-time interaction with the tissue. For instance,
real-time procedures facilitated the detection of sentinel
nodes (Supplementary Figures S1 and S2). Although the poor
penetration of light limits visualization of nodes to within
2 cm of the skin surface, it is nonetheless helpful to the
surgeon to be able to directly visualize the node through the
skin in real-time before a sentinel-node resection (Supple-
mentary Movie S1). The deep lymphatic system may not be
visualized through the skin due to poor tissue penetration of
visible light. This can be partly overcome by the increased
brightness of Qdots. Meanwhile real-time imaging allows the
direct manipulation (for example, stretching) of the skin to
reduce the light path length. It is only necessary to detect a
vague signal from deep to the skin, which can be easily seen




























Figure 1. Selection of Qdots used in this study. (a) White-light image (upper)
and fluorescence image (lower) of carboxyl quantum dots (From left to right;
Qdots 525, 545, 565, 585, 605, 655, 705, and 800). Fluorescence image was
excited by 365-nm ultra-violet light, and captured with a commercial-grade
digital camera used in this study. Each visible-light Qdots show its distinct
fluorescence, whereas two near-infrared Qdots (Qdot 705 and 800) are not
visualized in the fluorescence image. (b) Graph of the emission spectra of each of
the five carboxyl quantum dots used in this study (From left to right; Qdots 545,
565, 585, 605, and 655). (c) Schematic illustration of sites of injection in mice.
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Figure 3. Serial in vivo fluorescence images at day 0 to day 7 and in situ fluorescence images at day 7. On day 1, signal is reduced compared to day 0. From
day 1 to day 7, however, there are less marked reductions in signal, except in the left deep neck lymph node (Qdot 565), which becomes harder to see because





White light Pseudo-color composite Overlay
Qdot 545 (Green) Qdot 565 (Yellow) Qdot 585 (Orange) Qdot 605 (Magenta) Qdot 655 (Red)
ex vivoin situin vivo
Figure 2. Multicolor fluorescence lymphatic images. (a) Spectral fluorescence imaging needs to create spectral unmixed images of each Qdot and then creates
‘‘pseudo-color’’ images to overlay on the white-light image. (b) Real-time fluorescence imaging does not require such post-processing, permitting real-time
imaging. In this illustration a right superficial neck lymph node receives lymphatic drainage from two different lymphatic basins (arrows).
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during open surgery in real-time as shown in Supplementary
Movie S2.
There is a limitation to this current imaging system. The
color difference between Qdot 605 and 655 is not obvious
especially in in vivo images (Figures 2b and 3b). However,
the color difference among the five Qdots was clearly
distinguishable even in in vivo imaging with direct visualiza-
tion without a camera system. This ambiguity can be
improved using a camera system with a well-tuned color
balance close to naked eyes. Thus, this is unlikely to be a
potential impediment to further development of a fluores-
cence-guided surgical assistance system.
The toxicity of Qdots and their excretion from the body
remains another potential limitation for clinical translation
(Hardman, 2006; Iga et al., 2007), because most Qdots are
composed of heavy metals (for example cadmium and
selenium in very small amounts). Robe et al. (2008) reported
the biodistribution of intradermally injected carboxyl-Qdot
655 in the footpad of the mouse after 24 hours, and found that
Qdots were not detected within the organs but could be
found in the axillary lymph nodes on the injected side and at
the injection site. The author suggested that systemic uptake
of intradermally injected Qdots was negligible at 24 hours,
so that surgical resection of the injected skin effectively
removed residual Qdots from the body. Surface coatings and
appropriate sizes may improve the pharmacokinetics and
accelerate the removal of the agent from the body thus
reducing toxicity (Ballou, 2005; Zhang et al., 2006). Smaller
Qdots below 6nm in diameter are thought to be cleared
through the kidney and rapidly excreted into the urine
(Choi et al., 2007). Moreover, the dose of Qdots needed for
visualizing lymphatics is low and might be below the
toxicity threshold in humans, but this issue remains to be
investigated.
This real-time multicolor lymphatic imaging method can
be applied to any part of the body in mice (Supplementary
Figure S5). Moreover, we have recently demonstrated that
Qdot-labeled melanoma cells migrate through draining
lymphatics identified with fluorescent nanoparticles injected
intradermally (Kobayashi et al., 2009). Multicolor cell
tracking in the lymphatic system could be another research
tool for real-time multicolor lymphatic imaging in cancer
research. As the human body size is much larger than the
mouse, the use of this method in humans will require further
advancements in Qdot technology including minimizing the
amount of heavy metals (for example, Cadmium) while
retaining the same high efficiency. In addition, improved
imaging technologies that enable deeper visualization will be
important for clinical translation.
In conclusion, we successfully demonstrated in vivo
visible real-time multicolor lymphatic imaging in mice using
five different Qdots with distinct visible-range emissions. This
enabled simultaneous, but separate observation of multiple
lymphatic basins in real-time, which persisted up to at least 7
days. This method could have a considerable potential in
lymphatic research for studying the anatomy and flow within
the lymphatic system as well as in some limited clinical
settings where real-time visible fluorescence could facilitate
the procedures under surgery or endoscopy.
MATERIALS AND METHODS
Quantum dots
Eight carboxyl quantum dots (Qdot 525 ITK, Qdot 545 ITK, Qdot
565 ITK, Qdot 585 ITK, Qdot 605 ITK, Qdot 655 ITK, and Qdot 705
ITK, Qdot 800 ITK), which have thin coatings and small sizes, were
purchased from Invitrogen Co. (Carlsbad, CA).
In vivo real-time multicolor lymphatic imaging
All in vivo procedures were carried out in compliance with the
Guide for the Care and Use of Laboratory Animal Resources (1996),
National Research Council, and approved by the National Cancer
Institute Animal Care and Use Committee. Ten-week-old normal
Figure 4. Intranodal localization of Qdots. Hematoxylin and eosin staining
and fluorescence microscopic images of right axillary lymph nodes (containing
Qdot 655) at day 0 (a and b) and day 7 (c). At day 0, Qdots mainly accumulated
in the lymphatic sinuses, whereas lymphoid follicles and lymphatic cords were
spared (a). The distribution of Qdots corresponds to the expected lymph fluid
distribution within lymph nodes. At high magnification, the Qdots appear
nodular with dark areas in the center rather than diffusely distributed (b),
indicating that Qdots accumulate in the cytoplasm of cells within the lymphatic
sinuses. After 7 days, the Qdot accumulation is sparser than on day 0, but is still
nodular (c). HAM56 staining image is well correlated with the distribution
of Qdots within macrophages and dendritic cells (d). Scale bars of a, b, c,
and d¼ 100, 20, 100, and 25mm, respectively.
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athymic female mice were anesthetized through intraperitoneal
injection of 1.15mg sodium pentobarbital (Nembutal Sodium
Solution, Ovation Pharmaceuticals Inc., Deerfield, IL). Among all
available eight carboxyl-Qdots, five cadmium–selenium Qdots
(Qdot 545, Qdot 565, Qdot 585, Qdot 605, and Qdot 655) were
selected in this experiment because of adequate visual color
differences (Figure 1a and b). Seven mice were injected subdermally
with 20ml of each Qdot solution (1.6 mM for Qdot 545, 565, and 585,
or 0.8 mM for Qdot 605 and 655) into five different sites: the middle
phalanges of the upper extremities (left and right), the ears (left and
right), and the chin, as described in Figure 1c. Within 5minutes after
injection, in vivo visible multicolor fluorescence imaging was
performed with a modified real-time fluorescence imaging system
(FluorVivo, INDEC BioSystems, Santa Clara, CA). An excitation
band-pass filter of 450–490 nm and an emission long-pass filter of
520 nm were used. For still images, the real-time video camera was
replaced with a commercial-grade digital camera (CoolPix5400,
Nikon, Tokyo, Japan) and a digital video camcorder (PV-GS400,
Panasonic Corporation of North America, Secaucus, NJ). As a
control, in vivo spectral fluorescence imaging was performed using a
spectral imaging system (Maestro In Vivo Imaging System, CRI Inc.,
Worburn, MA), with 445–490 nm excitation band-pass filter and
515nm long-pass emission filter. The tunable filter was automati-
cally stepped in 10 nm increments from 500 to 800 nm using the
same exposure time at each wavelength resulting in one image every
30 seconds. The collected spectral fluorescence images were
processed with an unmixing algorithm (Maestro ver2.4, CRi). After
obtaining in vivo images, four of seven mice were killed, and the
lymph nodes were exposed for in situ fluorescence imaging. All
removed lymph nodes were also imaged with the same settings as
the in situ images.
Serial in vivo fluorescence imaging
The three mice that were not killed underwent serial in vivo
fluorescence imaging to investigate the duration of nodal visualiza-
tion. Imaging sessions took place at 1, 2, and 7 days after injection of
Qdots and then the mice were killed and underwent in situ and ex
vivo fluorescence imaging. Imaging protocols were the same as
described above.
Histological analysis
After removal and ex vivo fluorescence imaging, the right axillary
lymph nodes (containing Qdot 655) were fixed with 10%
formaldehyde and was evaluated by fluorescence microscopy
(Olympus BX61 microscope, Olympus America Inc., Melville, NY)
equipped with excitation band-pass filter 530–585 nm and emission
band-pass filter 605–680 nm. Immunohistochemical staining was
also performed with the same lymph node samples. Macrophages/
dendritic cells, B cells and T cells were identified by HAM56, anti-
CD20, and anti-CD3 antibodies, respectively. The fluorescence
signal from Qdot 655 was co-registered with the signals from the
immunohistochemical markers. Hematoxylin and eosin staining
were also performed and evaluated.
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